Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Nasdaq Biotechnology Ishares ETF (IBB)

Nasdaq Biotechnology Ishares ETF (IBB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BlackRock iShares
  • Assets Under Management 11,187,756,000
  • Shares Outstanding, K 66,100
  • 60-Month Beta 0.94
Trade IBB with:
  • Price/Earnings ttm 35.35
  • Annual Dividend & Yield 0.28 (0.17%)
  • Most Recent Dividend 0.023 on 06/10/21
  • Management Fee 0.46%
  • Sectors:

Options Overview

Details
  • Implied Volatility 21.79%
  • Historical Volatility 17.76%
  • IV Percentile 17%
  • IV Rank 23.76%
  • IV High 36.01% on 10/28/20
  • IV Low 17.36% on 06/25/21
  • Put/Call Vol Ratio 0.14
  • Today's Volume 8,338
  • Volume Avg (30-Day) 5,079
  • Put/Call OI Ratio 1.14
  • Today's Open Interest 91,423
  • Open Int (30-Day) 95,643

Price Performance

See More
Period Period Low Period High Performance
1-Month
157.11 +9.57%
on 07/15/21
173.64 -0.86%
on 08/04/21
+7.41 (+4.50%)
since 07/02/21
3-Month
143.05 +20.34%
on 05/11/21
173.64 -0.86%
on 08/04/21
+21.88 (+14.56%)
since 05/04/21
52-Week
126.00 +36.63%
on 09/04/20
174.04 -1.09%
on 02/10/21
+34.47 (+25.04%)
since 08/04/20

Most Recent Stories

More News
Delta Variant Surge Brings Biotech ETFs in Focus

The biotech sector seems like a lucrative investment space as the delta variant of coronavirus continues to spread.

SNY : 49.88 (-3.15%)
AAPL : 146.95 (-0.28%)
TGT : 260.53 (-0.64%)
WMT : 142.84 (-0.68%)
MRNA : 419.05 (+8.42%)
IBB : 172.15 (+1.62%)
TBIO : 37.85 (+0.48%)
FB : 358.92 (+2.19%)
GOOGL : 2,702.51 (-0.37%)
XBI : 124.80 (-0.02%)
BBH : 217.61 (+2.77%)
FBT : 173.52 (+1.49%)
BTEC : 56.18 (+1.13%)
Dyadic Int'l (DYAI) Inks Deal Toward Potential Access to 40% of the World as Covid Vaccine Continues in Development

NVAX : 223.81 (+18.69%)
MRNA : 419.05 (+8.42%)
PFE : 45.19 (-1.07%)
JNJ : 173.36 (-0.59%)
BNTX : 414.44 (+17.80%)
AZN : 57.31 (-0.61%)
IBB : 172.15 (+1.62%)
DYAI : 3.56 (+6.59%)
Delta Means Beta Testing Alpha Strategies in Biotech (NVAX, MRNA, DYAI, PFE, JNJ, BNTX, AZN, IBB)

PFE : 45.19 (-1.07%)
JNJ : 173.36 (-0.59%)
BNTX : 414.44 (+17.80%)
AZN : 57.31 (-0.61%)
IBB : 172.15 (+1.62%)
NVAX : 223.81 (+18.69%)
DYAI : 3.56 (+6.59%)
MRNA : 419.05 (+8.42%)
Moderna Soars on Inclusion to S&P 500: ETFs in Focus

Moderna, known for its success in the COVID-19 vaccine, has entered the big league with its addition to the S&P 500 Index.

ALXN : 182.50 (+1.70%)
IBB : 172.15 (+1.62%)
BBH : 217.61 (+2.77%)
GERM : 44.46 (+4.37%)
IBBQ : 26.77 (+1.75%)
Moderna ETFs to Rise on Positive COVID-19 Vaccine Updates

Moderna has once again come up with interesting updates about its COVID-19 vaccine.

AZN : 57.31 (-0.61%)
PFE : 45.19 (-1.07%)
MRNA : 419.05 (+8.42%)
IBB : 172.15 (+1.62%)
BBH : 217.61 (+2.77%)
IDNA : 52.50 (+2.78%)
GERM : 44.46 (+4.37%)
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 76.54 (+0.47%)
AMGN : 228.31 (-6.46%)
ALXN : 182.50 (+1.70%)
IBB : 172.15 (+1.62%)
TECH : 486.75 (+1.14%)
XBI : 124.80 (-0.02%)
Dow has Worst Week of the Year on Rate Hike Fears

Dow has Worst Week of the Year on Rate Hike Fears

IBB : 172.15 (+1.62%)
IBBQ : 26.77 (+1.75%)
AMGN : 228.31 (-6.46%)
GILD : 69.24 (-0.84%)
MRNA : 419.05 (+8.42%)
BIIB : 338.10 (+0.03%)
SHOP : 1,555.52 (+2.16%)
SWBI : 24.93 (-1.23%)
CUTR : 51.79 (-3.29%)
Biogen's Alzheimer's Drug Approval Puts Biotech ETFs in Spotlight

The FDA's approval of the first new drug to treat Alzheimer's disease in about 20 years has attracted investors' attention toward the biotech sector while sparking new controversies.

BIIB : 338.10 (+0.03%)
IBB : 172.15 (+1.62%)
XBI : 124.80 (-0.02%)
BBH : 217.61 (+2.77%)
FBT : 173.52 (+1.49%)
BTEC : 56.18 (+1.13%)
Should You Buy Biotech ETFs Now?

Biotech stocks are rallying this month; can the trend continue?

BIIB : 338.10 (+0.03%)
AMGN : 228.31 (-6.46%)
GILD : 69.24 (-0.84%)
MRNA : 419.05 (+8.42%)
IBB : 172.15 (+1.62%)
INO : 8.76 (+1.74%)
XBI : 124.80 (-0.02%)
CLOV : 7.92 (-2.46%)
IBBQ : 26.77 (+1.75%)
ETFs to Win as Moderna Seeks COVID-19 Vaccine Nod for Teens

Moderna (MRNA) is once again in the spotlight with an impressive update relating to mRNA-1273.

MRNA : 419.05 (+8.42%)
IBB : 172.15 (+1.62%)
BBH : 217.61 (+2.77%)
IDNA : 52.50 (+2.78%)
GERM : 44.46 (+4.37%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Fund Summary

The iShares Nasdaq Biotechnology ETF seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ. The Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the NASDAQ Biotechnology...

See More

Key Turning Points

3rd Resistance Point 179.37
2nd Resistance Point 176.50
1st Resistance Point 174.33
Last Price 172.15
1st Support Level 169.29
2nd Support Level 166.42
3rd Support Level 164.25

See More

52-Week High 174.04
Last Price 172.15
Fibonacci 61.8% 155.69
Fibonacci 50% 150.02
Fibonacci 38.2% 144.35
52-Week Low 126.00

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar